期刊文献+

多烯紫杉醇磺丁基醚-β-环糊精包合物的增溶作用及制备 被引量:5

Solubility and preparation of docetaxel inclusion complexes using sulfobutyl-etherl-β-cyclodextrin
原文传递
导出
摘要 目的:制备多烯紫杉醇磺丁基醚-β环糊精(SEB-β-CD)包合物,提高药物的溶解度。方法:采用冷冻干燥法制备包合物,考察磺丁基醚-β-环糊精与药物在不同主客分子比例、不同制备时间、不同制备温度时多烯紫杉醇的增溶作用,并利用差示扫描量热法(DSC)、红外光谱法(IR)、X-射线衍射法和1H-NMR核磁共振法对所制备的包合物进行结构验证,选择最佳制备工艺。结果:当药物与SEB7-β-CD摩尔比均为1∶70,制备时间2h,制备温度25℃时,多烯紫杉醇增溶效果最好,溶解度为442.21mg.L-1。经结构验证,说明形成包合物。结论:利用制备多烯紫杉醇环糊精包合物的方式,可显著提高药物的溶解度。 OBJECTIVE To investigate the inclusion complexes of docetaxel (DTX) with sulfobutyl-etherl-β-cyclodextrin (SEB-β-CD). METHODS The solid inclusion complexes of DTX/SEBT-β-CD were prepared in different mole ratios, reaction time and temperature by freezed drying method. The characteristics of which were studied preliminarily by in vitro dissolution test, differential scanning calorimetry(DSC), X ray diffraction, infra red spectroscopy,^1H NMR. RESULTS Total drug solubility was evidently increased to 442.21 mg·L^-1 under mole ratios 1:70, 2 h reaction time at 25 ℃. The solid inclusion complexes were formed according to structure verification test. CONCLUSION The e solubility of DTX was improved by SEB7-β-CD complexation obviously.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2010年第18期1541-1545,共5页 Chinese Journal of Hospital Pharmacy
关键词 多烯紫杉醇 磺丁基醚-Β-环糊精 包合物 溶解度 制备 docetaxel sulfobutyl-etherl-β-cyclodextrin inclusion complexes dissolution preparation
  • 相关文献

参考文献4

二级参考文献57

  • 1张学农,唐丽华,阎雪莹,张强.注射用紫杉醇的制备及过敏试验[J].中国医院药学杂志,2005,25(1):35-37. 被引量:3
  • 2代国飞,王明伟.环糊精及其衍生物的药学应用进展[J].中国新药杂志,2005,14(11):1261-1264. 被引量:23
  • 3郑筱萸 廖清江.药学前沿(2001卷)[M].北京:中国医药科技出版社,2002.46-59.
  • 4Kim JH, Lee SK, Ki MH, et al. Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin [ J ]. Int J Pharm,2004, 272(1-2) :79 - 89.
  • 5Arima H,Yunomae K, Miyake K, et al. Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats [ J ]. J Pharm Sci, 2001, 90 (6):690 - 701.
  • 6Nagase Y, Hirata M, Wada K, et al. Improvement of some pharmaceutical properties of DY-9760e by sulfobutyl ether beta-cyclodextrin[J]. Int J Pharm, 2001, 229(1-2):163- 172.
  • 7Piel G, Evrard B, Van Hees T, et al. Comparison of the Ⅳ pharmacokinetics in sheep of miconazole-cyclodextrin solutions and a micellar solution[J]. Int J Pharm, 1999,180(1) :41 - 45.
  • 8Stella VJ,Rao VM, Zannou EA, et al. Mechanisms of drug release from cyclodextrin complexes[J]. Adv Drug Deliv Rev, 1999,36( 1 ):3- 16.
  • 9Nagase Y, Arima H, Wada K, et al. Inhibitory effect of sulfobutyl ether beta-cyclodextrin on DY-9760e-induced cellular damage: In vitro and in vivo studies[J]. J Pharm Sci, 2003,92(12): 2466 -2474.
  • 10Partyka M, Au BH, Evans CH. Cyclodextrins as phototoxicity inhibitors in drug formulations: studies on model systems involving naproxen and beta-cyclodextrin[ J ]. J Photoch Photobio A, 2001,140(1):67-74.

共引文献84

同被引文献56

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部